SAMPLE REPORT · fictional profile for illustration · your report is personalized to your own intake
30-Day Full Report · Jennifer R. · PR-30-2026-10043Enable "Background graphics" in your browser print dialog for full color printing
PeptideReport.aiPR-30-2026-10043 · May 21, 2026
Your 30-Day Full Report
Personalized educational framework · Not medical advice or a clinical recommendation
Age / Sex
47 · Female
Height
5′ 4″
Weight
162 lb
Goal weight
148 lb
Activity
Light
Sleep / night
5.5 hrs ⚠
Educational use only — paid report tier. This report is AI-assisted and is not medical advice, diagnosis, treatment, or prescribing.
Research compounds require professional guidance, sterile sourcing, and individual evaluation.
Same-day use does not mean same-syringe compatibility — never assume without professional confirmation.
All dosing, timing, reconstitution, and protocol references are educational frameworks only.
Dose figures referenced for research compounds are educational reference from published trials (Jastreboff, NEJM 2023), used only under clinician supervision.
This 30-Day Full Report provides a practical educational framework — including compound context, protocol dose references, reconstitution concepts, timing organization, safety cautions, and a structured starting guide. This report is educational scaffolding, not a prescription. It is designed to help you have a more informed, specific, and productive conversation with your licensed professional.
Your focus"I feel like I've aged 10 years in the last 2. My skin, my energy, my mood — everything feels off."
Sleep flag: At 5.5 hours per night, sleep falls below the threshold associated with healthy collagen synthesis, cortisol regulation, and hormonal recovery — directly relevant to Jennifer's top concerns across skin, mood, energy, and immune resilience.
🚩Read this before you continue
What you're about to see may surprise you.
The section below shows the wellness categories matched to your profile — along with real compound names studied in each category. A list of compound names without the framework behind them is where confusion typically begins. This report goes further — providing the practical educational framework behind every compound listed.
Section 1 — Matched educational categories
Five categories most relevant to your goals
Primary match
Skin / Aesthetic
Collagen support, skin quality, visible aging, tissue repair, and appearance-related wellness goals. Your high concern around visible skin aging and collagen loss makes this your top educational priority.
GHK-CuCJC-1295IpamorelinBPC-157Epithalon
Primary match
Hormone Signaling
Recovery quality, sleep support, lean tissue signaling, vitality, and age-related hormonal changes. Particularly relevant for women approaching or in perimenopause experiencing sleep disruption and mood changes.
CJC-1295IpamorelinTesamorelinKisspeptinMOTS-c
Supporting
Neurological
Focus, mental clarity, mood resilience, stress response, and cognitive performance. Your high brain fog and mood scores place this as a meaningful supporting category.
SemaxSelankDSIPNAD+Cerebrolysin
Supporting
Energy / Mitochondrial
Fatigue, low stamina, and cellular energy production. At 5.5 hours of sleep and with high cognitive load, mitochondrial support is a natural complement to the primary categories.
MOTS-cSS-31NAD+5-Amino-1MQDSIP
Supporting
Immune / Inflammatory
Immune balance, inflammation support, and overall resilience. Chronic sleep deprivation and high stress load both elevate inflammatory markers — supporting this category may have downstream benefits across all five areas.
Thymosin Alpha-1KPVBPC-157TB-500Selank
⚡ Critical context — do not skip this
Knowing the names is only the beginning. Understanding how to use them is an entirely different conversation.
The compounds listed above are educational examples only — not a recommendation, not a protocol, and not a complete picture. This is an important limitation of any category-level overview. Knowing which peptide categories may align with your goals is useful, but it does not explain how those categories should be interpreted in practice.
Peptide education becomes significantly more complex once the following enter the conversation:
Vial strengthReconstitution conceptsDose interpretationSyringe-unit mathTiming considerationsToleranceSafety distinctionsCompatibility questionsSame-vial vs. same-syringeFasting contextFoundational vs. later-stage compoundsLong-horizon pathways
Many people reach this point with a list of possible compounds but no clear structure for understanding them. That gap leads to confusion, unnecessary spending, mismatched expectations, or reliance on incomplete information from forums, videos, and informal protocols.
The sections that follow provide the practical educational framework needed to understand how these compounds are commonly organized, interpreted, and approached — so you can make the most informed decisions possible for your situation.
Section 2 — How these categories interconnect
Understanding the relationship between your matched areas
Jennifer's five matched categories are not five separate problems — they are five expressions of the same underlying picture. Chronic sleep deprivation at 5.5 hours directly suppresses growth hormone release, which impairs collagen synthesis, skin repair, and lean tissue recovery. It elevates cortisol, which worsens mood, accelerates visible aging, and blunts immune function. Reduced GH signaling also diminishes mitochondrial efficiency, contributing directly to low energy and brain fog. The hormone signaling and skin categories are the anchors — supporting them while addressing sleep quality creates a cascade effect across energy, neurological clarity, and immune resilience.
⚠️Before you go further — critical handling and sourcing awareness
The compounds referenced in this report are only as reliable as the way they are handled, sourced, and prepared. This is one of the most overlooked areas in peptide education — and one of the most consequential. Understanding compound categories is step one. Understanding what can compromise them before they ever reach you is equally important.
🧪
Never mix peptides into the same vial
Combining multiple peptides into one vial — before or after reconstitution — can create an unstable, unpredictable solution. Different peptides may have conflicting pH requirements, solubility profiles, and degradation patterns. Once combined, you may no longer have a reliable product. The mixture may oxidize, precipitate, lose potency, or become impossible to evaluate. A poorly mixed vial can destroy an entire plan before the first use.
🏷️
Branded blend names are not proof of quality or compatibility
Many peptide products are marketed under consumer-friendly stack names that make complex mixtures sound simple and targeted. These names do not prove stability, compatibility, sterility, or appropriateness for the individual user.
Wolverine StackGlow BlendKLOW BlendRecovery BlendGH BlendFat Loss StackLongevity BlendSuper StackAll-in-One Formula
⚗️
GHK-Cu requires special separation — always
GHK-Cu contains copper, which may accelerate degradation or create compatibility problems when combined with other peptides in the same vial. GHK-Cu must always be handled separately and never mixed with other compounds unless a qualified pharmacy has specifically verified the formulation. This includes products marketed under "Glow" or "KLOW" style blend names.
💧
bacteriostatic (BAC) water quality can ruin an entire vial
Reconstitution solution is not a minor supply item. A contaminated, improperly formulated, or chemically incompatible diluent can compromise a peptide immediately — even if the peptide itself was correctly sourced and stored. Results become impossible to evaluate fairly.
❌ Avoid these sourcing approaches for BAC water and reconstitution supplies
✗Amazon "BAC water" listings or reconstitution kits
✗Anonymous online sellers and marketplace storefronts without verified pharmacy credentials
✗Social media vendors and generic "research supply" websites
✗Unlabeled, relabeled, or unverified reconstitution products
✓ Preferred standard
Use only sterile, pharmaceutical-grade bacteriostatic water or an appropriate qualified diluent obtained through a licensed pharmacy, qualified medical source, or licensed professional. A peptide plan is only as reliable as the compounds, the reconstitution process, the storage conditions, and the compatibility decisions behind it.
🚨Critical Warning: Avoid Peptide Scams and Ineffective Delivery Systems
Beware of companies promoting sublingual drops, lozenges, oral capsules, nasal sprays, or any "easy" non-injection delivery methods. These products are almost always ineffective and prey on people looking for convenience.
Most research peptides are large, water-soluble molecules rapidly broken down by enzymes in the mouth, stomach, or nasal mucosa. Scientific literature consistently shows they have extremely poor or zero meaningful absorption through these routes. Only subcutaneous injection has demonstrated reliable absorption and consistent results in laboratory research settings.
If a company is pushing sublingual, oral, or other "no-needle" options as effective alternatives, it is almost certainly a scam. Always verify any peptide product comes from a reputable supplier with third-party testing (COA — Certificate of Analysis).
A limited number of compound-specific, route-specific exceptions are supported by research:
✓ Intranasal: Semax and Selank (developed in Russia specifically as nasal sprays, documented nose-to-brain delivery) · Oxytocin (~11% nasal bioavailability, extensively studied) · Epithalon (small tetrapeptide, 390 Da, some nasal research)
✓ Topical (skin-local only, not systemic): GHK-Cu serums and creams (cosmetic, skin-surface only)
✗ Do not exist or not validated: Oral Tirzepatide — does not exist in any approved form as of May 2026 — products sold online are unapproved and dangerous) · Generic sublingual peptide drops · BPC-157 standard nasal spray (no human research, quality control issues)
Section 2b — Root-cause thesis
The one idea this whole protocol is built around
Short sleep is the upstream driver. At 5.5 hours a night, growth-hormone release is suppressed and cortisol stays elevated — which is why skin, energy, mood, and recovery are all slipping at once.
Your five matched categories are not five separate problems — they are five expressions of the same picture. Restoring sleep and the growth-hormone (GH) axis is the foundation; skin, mitochondrial energy, neurological clarity, and immune resilience cascade from it. The plan is sequenced so the foundation goes first and everything else builds on it.
Section 3 — Compound educational overview
Compounds most commonly discussed for your categories
GHK-Cu
ResearchModerate onset
Skin / Aesthetic🌙 Evening — solo use
Copper peptide studied for collagen stimulation, wound healing, skin repair, and hair follicle support. Gradual onset — typically first noticed at 4–8 weeks with consistent use.
CJC-1295 + Ipamorelin
ResearchModerate onset
Hormone Signaling🌙 Bedtime
GH-releasing hormone analogue paired with GH secretagogue. Discussed for sleep quality, lean tissue support, recovery, and GH pathway signaling. Bedtime timing aligns with natural GH release patterns.
Semax
ResearchFast onset
Neurological☀ Morning
ACTH-derived neuropeptide studied for focus, cognitive clarity, mood resilience, and stress adaptation. May produce noticeable cognitive effects relatively quickly for some individuals.
Selank
ResearchFast onset
Neurological☀ Morning or daytime
Anxiolytic peptide studied for stress resilience, mood regulation, and calm focus. Often discussed alongside Semax as a complementary neurological support compound.
MOTS-c
ResearchModerate onset
Energy / Mitochondrial☀ Morning
Mitochondrial-derived peptide studied for cellular energy regulation, metabolic support, and exercise performance. Morning timing aligns with natural metabolic rhythm.
Thymosin Alpha-1
ResearchSlow onset
Immune / InflammatoryFlexible timing
Thymic peptide studied for immune modulation, resilience, and inflammatory balance. Effects are cumulative — typically 4–12 weeks of consistent use before meaningful differences are reported.
Retatrutide
ResearchModerate onset
Weight LossOnce weekly · research compound
GLP-1/GIP/glucagon triple-pathway agonist. Appetite suppression typically noticed early. GI side effects commonly reported at initiation.
Section 4 — Protocol dose reference
Educational dose framework, reconstitution, and unit reference
On dosing frequency — one approach, confirm with your clinician. The frequencies and schedules in this report reflect one clinical approach. The same compounds are discussed at different frequencies across the peptide community, and there is no single "correct" schedule. Use what's here as a starting framework and confirm the frequency that's right for you with your clinician.
On reconstitution — one standard, not the only one. The dilutions shown for each peptide — the vial size paired with the BAC water volume — reflect one common reconstitution standard. Many other dilution ratios are used throughout the peptide community; a different diluent volume changes the units you draw per dose, not the dose itself. Use what's here as a reference and confirm your reconstitution approach with your clinician.
Educational reference — read before using this section
All dose ranges, reconstitution examples, syringe unit calculations, timing references, and frequency notes below are based on general educational observations from biohacking communities, peer discussions, and publicly available research references. Units are rounded to the nearest practical syringe mark. All dosing and protocol decisions should be evaluated by a licensed pharmacist or clinician before use. Peptides and related products are strictly for laboratory research use and are not intended for human consumption, diagnosis, treatment, or any medical purpose.
GHK-Cu
ResearchSkin / Aesthetic
Vial / Diluent
50 mg / in your report BAC water
~in your report
Dose range
in your report
25–50 uses per vial
Frequency
5 days on / 2 days off
Week 1: lower dose only
Average dose: Wk1: 1,000 mcg → 5u · Wk2+: 2,000 mcg → 10u
Syringe unit reference — 50 mg vial + in your report BAC water
💉 Week 1: in your report → in your report (rounded down for measurement ease)
💉 Week 2 onward: 2,000 mcg → in your report (rounded down for measurement ease)
→ denotes units rounded down to an easy whole unit for simpler, safer measurement. At in your report / in your report, exact values are ~6u and ~in your report; the rounded in your report/in your report draw is intentional and slightly conservative.
⏰ Timing: Flexible — no strict AM or PM rule. Evening or pre-bed is the most frequently referenced timing for skin and collagen goals, as skin regeneration and collagen repair are thought to peak during sleep. Morning use is also reported with no noticeable difference by many users. Consistency matters more than the specific time. No fasting required.
About GHK-Cu: Copper peptide studied for collagen stimulation, wound healing, skin repair, and hair follicle support. Gradual onset — typically first noticed at 4–8 weeks with consistent use.
⚠ Solo use only — never combine in the same syringe with other peptides. Assess tolerance in Week 1 at 1,000 mcg. If tolerated, may increase to 2,000 mcg in Week 2. Redness, itching, or rash may result — evaluate an alternative injection site if reactions occur.
CJC-1295
ResearchHormone Signaling
Vial / Diluent
5 mg / in your report BAC water
in your report
Dose range
in your report
17–50 uses per vial
Frequency
5 days on / 2 days off (PM)
Bedtime, fasted
Average dose: 250 mcg = in your report
Syringe unit reference — in your report vial + in your report BAC water
💉 100 mcg = in your report · in your report = in your report · 250 mcg = in your report · in your report = in your report
About CJC-1295: Growth hormone-releasing hormone analogue studied for GH pulse stimulation, lean tissue support, sleep quality, and recovery. Works by stimulating the pituitary to release growth hormone naturally. Effects are cumulative — sleep quality improvements are often reported first, with body composition changes typically requiring 4–8 weeks of consistent use.
⚠ Fasting required — not optional. GH peptides taken without fasting have drastically reduced efficacy. Insulin suppresses GH release directly. Fasted 90 minutes before AND 90 minutes after dosing. No carbs or protein before injection.
⏰ Timing: Bedtime only — strictly fasted. Fasted 90 minutes before AND 90 minutes after dosing. Commonly drawn into same syringe as Ipamorelin.
Ipamorelin
ResearchHormone Signaling
Vial / Diluent
5 mg / in your report BAC water
in your report
Dose range
in your report
10–50 uses per vial
Frequency
5 days on / 2 days off (PM)
Week 1: 100 mcg = in your report
Average dose: Wk1: in your report · Wk2+: in your report
Syringe unit reference — 5 mg vial + in your report BAC water
💉 Wk 1: in your report (in your report tolerance test) · Wk 2+: 250 mcg = in your report · in your report = in your report
About Ipamorelin: Selective growth hormone secretagogue studied for GH release, lean muscle support, recovery, and sleep quality. Known for a clean GH pulse with minimal effect on cortisol or prolactin compared to other secretagogues. Most commonly paired with CJC-1295 for a synergistic GH stack. Onset typically 2–6 weeks with consistent bedtime use.
⚠ Fasting required — not optional. Same rule as CJC-1295: food before use blunts GH release and significantly reduces effectiveness. Fasted 90 minutes before AND 90 minutes after dosing.
⏰ Timing: Bedtime or post-workout — strictly fasted. Fasted 90 minutes before AND 90 minutes after dosing. Week 1: start at 100 mcg to assess tolerance before stepping up to in your report.
Semax
ResearchNeurological
Vial / Diluent
in your report / in your report BAC water
5,000 mcg/mL
Dose range
in your report
5–20 uses per vial
Frequency
5 days on / 2 days off
AM or early afternoon
Average dose:in your report = in your report · 500 = 10u
Syringe unit reference — in your report vial + in your report BAC water
💉 in your report = 5u · in your report = in your report · in your report = 20u
About Semax: ACTH-derived neuropeptide studied for cognitive clarity, focus, mood resilience, and stress adaptation. Associated with BDNF upregulation and neuroprotective properties. One of the faster-acting neurological compounds — some individuals report noticeable cognitive effects within days to 1–2 weeks. Stimulating in nature — morning use is strongly preferred.
⏰ Timing: Morning or early afternoon only. Stimulating effect — avoid taking later in the day unless additional focus is specifically required. No fasting required. Can be drawn into the same syringe as Selank.
Selank
ResearchNeurological
Vial / Diluent
in your report / in your report BAC water
in your report
Dose range
250–500 mcg
10–20 uses per vial
Frequency
As needed
AM or PM depending on goal
Average dose:in your report = in your report · 500 = in your report
Syringe unit reference — 5 mg vial + in your report BAC water
💉 in your report = in your report · 500 mcg = in your report
About Selank: Anxiolytic heptapeptide studied for stress resilience, mood regulation, anxiety reduction, and calm focus. Derived from tuftsin and associated with GABAergic modulation. Complementary to Semax — where Semax activates, Selank calms. Can support both daytime focus and evening wind-down depending on timing. Effects often reported within days to 1–2 weeks.
⏰ Timing: AM or early afternoon for quiet focus and noise reduction. PM or evening if calming or sleep support effect is desired. No fasting required. Can be drawn into the same syringe as Semax.
MOTS-c
ResearchEnergy / Mitochondrial
Vial / Diluent
in your report / in your report BAC water
10,000 mcg/mL
Dose range
in your report
4 uses per vial
Frequency
2× weekly · Mon & Thu
Separate syringe always
Average dose:in your report = in your report
Syringe unit reference — 10 mg vial + in your report BAC water
💉 in your report = in your report on both 50-unit (half syringe) and 100-unit syringe
About MOTS-c: Mitochondrial-derived peptide studied for cellular energy regulation, metabolic support, insulin sensitivity, and exercise performance. Encoded in mitochondrial DNA — unique among peptides. Associated with improved fat oxidation and metabolic flexibility. Energy and stamina improvements typically reported after 2–4 weeks of consistent use.
⏰ Timing: AM fasted or 30–60 min prior to workout. Best taken before exercise for enhanced metabolic effect. Morning aligns with natural metabolic rhythm.
⚠ Separate syringe required. MOTS-c should not be drawn into the same syringe as other compounds due to pH sensitivity and mitochondrial-specific properties.
Thymosin Alpha-1
ResearchImmune / Inflammatory
Vial / Diluent
10 mg / in your report BAC water
in your report
Dose range
in your report
10–20 uses per vial
Frequency
Course-based
2x weekly × 3 weeks = 6 total uses · 1,600 mcg = in your report each
Average dose: 1,000 mcg = 10u · 1,600 mcg = 16u
Syringe unit reference — in your report vial + in your report BAC water
💉 500 mcg = in your report · in your report = in your report · 1,600 mcg = in your report
📅 Option A: in your report = in your report for 10 consecutive days (10-day course)
📅 Option B: 1,600 mcg = in your report · 2x weekly × 3 weeks = 6 total injections · repeat every 3 months
About Thymosin Alpha-1: Thymic peptide studied for immune modulation, inflammatory balance, and overall immune resilience. Naturally produced by the thymus gland — levels decline with age. Associated with T-cell activation and enhanced immune surveillance. Effects are cumulative and slow-building — rarely judged fairly in less than 4–8 weeks. Consistency is the most important factor for meaningful results.
⏰ Timing: Fully flexible — morning, midday, or evening are all commonly referenced. Short half-life (~2 hours) means the specific time of day is not considered critical. Morning or midday is the most frequently reported for convenience. Consistency with the twice-weekly schedule matters far more than the hour of the day. No fasting required. Can be drawn into the same syringe as most other compounds except GHK-Cu, MOTS-c, SS-31, and NAD+.
Retatrutide
ResearchWeight Loss
Average dose:in your report = in your report (8 mg vial) · in your report = in your report (in your report vial)
About Retatrutide: Triple-agonist GLP-1/GIP/glucagon receptor compound studied for significant fat loss, appetite regulation, and metabolic improvement. Distinguished from other GLP-1 compounds by its glucagon receptor activity, which may contribute to greater fat utilization. Appetite suppression is typically noticed early — meaningful weight changes generally require several weeks of consistent use.
Frequency
Once weekly
Never 5-on/2-off
8 mg vial + in your report BAC water
in your report × 4 weeks
Fill to in your report
16 mg vial + in your report BAC water
in your report × 4 weeks
Fill to in your report · or 8 mg = in your report
Syringe unit reference
💉 in your report vial + in your report BAC water: 2 mg dose = in your report · once weekly × 4 weeks
💉 in your report vial + in your report BAC water: 4 mg dose = in your report · once weekly × 4 weeks
💉 in your report vial + in your report BAC water: 8 mg dose = in your report · once weekly × 2 weeks
⚠ Taken alone — always its own dedicated syringe. Retatrutide is never combined with any other compound in the same syringe.
⏰ Timing: Once weekly — same day each week. No fasting requirement. A light meal or empty stomach may help manage initial GI side effects.
Nausea tolerance protocol: In week 1, split the dose to test tolerance — half on Monday, half on Thursday. From week 2, take the full dose every Monday. This approach allows your body to acclimate and significantly reduces the risk of nausea at initiation. GI effects are common early and typically subside with consistent weekly use. Do not use 5-on/2-off logic — weekly dosing only.
Sourcing note: Retatrutide is not FDA approved and is not available by prescription. It is currently available as a research compound through select research suppliers. Sourcing standards, purity, sterility, and legal status in your region are the responsibility of the individual. Quality of source matters significantly — prioritize verified, reputable suppliers.
Protocol reference — all compounds
Compound
Vial + Diluent
Dose
Average dose
Frequency
Timing
Fasting
Syringe
GHK-Cu
50 mg + 3 mL BAC
Wk1: 1,000 mcg Wk2+: 2,000 mcg
Wk1: 1,000 mcg → 5u Wk2+: 2,000 mcg → 10u
5 days on / 2 days off
Flexible · Pre-bed preferred
No
⚠ Separate
CJC-1295
yours + yours BAC
100–300 mcg
yours = yours
5 days on / 2 days off
Bedtime only
Yes · 90 min
Pairs w/ Ipamorelin
Ipamorelin
yours + 2 mL BAC
Wk1: yours Wk2+: yours
Wk1: yours · Wk2+: 10u
5 days on / 2 days off
Bedtime only
Yes · 90 min
Pairs w/ CJC-1295
Semax
yours + yours BAC
yours
250 mcg = yours · 500 = yours
5 days on / 2 days off
Morning only
No
Pairs w/ Selank
Selank
yours + 1 mL BAC
yours
yours = yours · 500 = 10u
As needed
AM focus · PM calm
No
Pairs w/ Semax
MOTS-c
yours + yours BAC
yours
2.5 mg = yours
2× weekly · Mon & Thu
AM fasted / pre-workout
Preferred
⚠ Separate
Thymosin A-1
yours + yours BAC
Option A: 1,000 mcg × 10 days Option B: yours 2x/wk × 3 wks
GH peptides (CJC-1295, Ipamorelin) — fasting is NOT optional. Efficacy drastically reduced without it. Fasted 90 min before AND 90 min after. | Never freeze reconstituted peptides. Store front of fridge. | GLP-1 nausea protocol: half dose Monday → remaining half Thursday → full dose every Monday from week 2.
Syringe compatibility reference
Mix only immediately before injection — never pre-mix in a vial or leave a loaded syringe to sit. Everything here is subcutaneous, same route. The groups below are one commonly used compatibility reference — other combining protocols are discussed across peptide forums and communities, and there is no single "correct" grouping. Your clinician confirms what applies to your protocol.
✓ BPC-157, TB-500 and KPV (the healing stack) join most groups above.
⚠ GHK-Cu — keep it stand-alone (client’s discretion). Some clinics combine it with the healing stack, but its copper content and pH sensitivity make a separate syringe the conservative standard — and injecting it alone means that if a skin reaction or side effect appears, you know exactly which compound caused it.
✗ Keep separate — its own syringe
Retatrutide and other GLP-1 / GIP agonists (Semaglutide, Tirzepatide), Melanotan-2, PT-141, VIP, Oxytocin, GHK-Cu, MOTS-c, SS-31, 5-Amino-1MQ, Epithalon, and any acetic-acid–reconstituted peptide.
Key rules
• Mix immediately before injection
• Plain BAC water — no saline (NaCl)
• Keep total volume low (≈0.5–1 mL)
• Draw the larger-volume peptide first
• Check for cloudiness — discard if present
• All subcutaneous (same route)
Syringe compatibility disclaimer
Compatibility information is based on community consensus, educational sources, and general biohacking references. Applies to immediate use only — not long-term vial storage. All mixing decisions should be reviewed with a licensed pharmacist or clinician. Source: Reddit r/Peptides, r/BioHackingGuide, LinkedIn peptide clinicians, 2025–2026 research references.
Section 5 — Vial and reconstitution concepts
Understanding vials, BAC water, and supply planning
What is reconstitution?
Most research peptides are supplied as a lyophilized (freeze-dried) powder. Before use, the powder is combined with bacteriostatic water (BAC water) to create a liquid solution. The amount of BAC water added determines the concentration. Your professional or pharmacy provides specific reconstitution instructions.
What is BAC water?
Bacteriostatic water is sterile water containing benzyl alcohol, which preserves the solution after the vial is opened. It is not the same as sterile water for injection. The correct diluent must be confirmed with your professional or pharmacy.
Storage requirements
Lyophilized powder is stored refrigerated at 2–8°C and protected from light. Once reconstituted, solutions are generally used within 28–30 days and kept refrigerated. Never freeze a reconstituted peptide solution — freezing after reconstitution can degrade the compound and compromise the entire vial. Store toward the front of the refrigerator, not the back — the back of most refrigerators runs colder and may approach freezing temperatures, which can damage the solution. Specific storage requirements vary by compound — confirm with your source or professional.
Section 6 — AM / PM organization
General timing framework for your matched compounds
Timing is educational context only. Your licensed professional confirms appropriate timing, frequency, and sequence for your specific situation.
Section 7 — Fasting considerations
How food timing relates to specific compounds
⚠ GH Peptides — Fasting is NOT optional. Efficacy is drastically reduced without it.
The following GH-pathway peptides MUST be taken in a fully fasted state: CJC-1295, Ipamorelin, Tesamorelin. Insulin from recent food intake actively suppresses GH release — directly counteracting the purpose of these compounds. Fasted 90 minutes before AND 90 minutes after dosing. No carbohydrates or protein before injection. This is a requirement, not a preference. Strict adherence to fasted timing is critical.
MOTS-c — fasted or light-fasted state preferred
Fasted or light-fasted state preferred for enhanced metabolic effect. Morning use in a fasted or lightly fasted state is commonly referenced for mitochondrial and metabolic compounds. Some discussions reference pre-exercise timing for enhanced metabolic effect. Confirm timing approach with your professional.
Retatrutide (and all GLP-1 compounds) — no strict fasting requirement
GLP-1 pathway compounds do not require a fasted state. Typically administered once weekly unless otherwise directed. No fasting required — taking with a light meal or on an empty stomach may help manage initial GI discomfort at the start of a protocol.
Tolerance protocol for nausea (recommended for all GLP-1 compounds): To test tolerance and reduce the risk of nausea at initiation, split the first week: take half the dose on Monday and the remaining half on Thursday. From week 2, take the full dose every Monday. This split approach allows the body to acclimate before committing to a full weekly dose. Do not apply 5-on/2-off logic to any GLP-1 compound — weekly dosing only.
GHK-Cu, Semax, Selank, Thymosin Alpha-1 — no fasting requirement
These compounds do not have commonly referenced fasting requirements. They can generally be used with or without food. Confirm any specific timing preferences with your professional based on your overall schedule.
Section 8 — Timeline expectations by compound
When effects are typically first reported
SemaxFast
Typical onset: Days to 1–2 weeks
Cognitive and mood effects may be among the earliest reported. Individual sensitivity varies.
SelankFast
Typical onset: Days to 1–2 weeks
Stress and mood effects often reported early. Subtle in some individuals, more pronounced in others.
MOTS-cModerate
Typical onset: 2–4 weeks
Energy and stamina improvements commonly reported after 2–4 weeks of consistent use.
RetatrutideModerate
Typical onset: 2–4 weeks
Appetite suppression typically noticed early. Meaningful weight changes require consistent use over weeks.
CJC-1295 + IpamorelinModerate
Typical onset: 2–6 weeks (sleep) · Body recomposition: up to 6 months
Sleep quality improvements are often the first noticeable change, typically within 2–6 weeks. Body composition changes — lean mass, recovery, fat reduction — are slower and cumulative. Meaningful recomposition may take up to 6 months of consistent use. Do not evaluate body composition results in a short window.
GHK-CuModerate
Typical onset: 4–8 weeks
Skin texture and collagen changes are gradual — often first noticed at 4–8 weeks with consistent use.
Thymosin Alpha-1Slow
Typical onset: 4–12 weeks · Repeat cycle every 3 months
Immune and inflammatory benefits are cumulative and slow-building. Rarely judged fairly in less than 4–8 weeks. Consistency with the twice-weekly schedule is critical. A full course is commonly discussed as a 30-day protocol — repeated every 3 months for sustained immune support. Do not evaluate effectiveness prematurely.
Individual results vary significantly. These timelines are general educational observations only — not guaranteed outcomes.
Section 8b — Protecting muscle and bone during weight loss
Losing weight fast is not only fat — protect what you don't want to lose
Rapid weight loss — the kind a GLP-1 pathway compound like Retatrutide can produce — is not all fat. A meaningful share of what comes off can be lean muscle, and over time, bone. The compound does the fat loss; the steps below are what keep the weight you lose to the weight you actually want to lose.
Why this matters. Clinical trials of GLP-1 / GIP compounds (Tirzepatide, Semaglutide) report that roughly 25–40% of total weight lost can be lean mass rather than fat. That is a better ratio than older rapid-weight-loss methods — but it still means real muscle loss, and it matters most for older adults, athletic individuals, and anyone already metabolically vulnerable.
1
Protein — the single most important lever
Target 1.0–1.2 g of protein per pound of goal body weight (goal weight, not current), spread across at least three meals — roughly 30–50 g each. On a GLP-1, with appetite down, hitting protein is the hardest and most important thing you will do. Your Meal Plan companion is built around this.
2
Resistance training — the signal to keep muscle
Even two full-body resistance sessions per week dramatically reduce lean-mass loss. A GLP-1 without resistance training carries a high muscle-loss risk; a GLP-1 with consistent lifting steers the loss toward fat. Two sessions a week is the floor; three to four is ideal. Your Movement companion lays out the sessions.
3
GH-pathway compounds — already in your protocol
CJC-1295 + Ipamorelin support lean mass through GH / IGF-1 signaling — one reason they sit alongside a weight-loss compound. Creatine monohydrate (3–5 g per day, non-peptide, well documented for preserving lean mass during caloric restriction) is a low-cost addition to discuss with your professional.
Bone density. Significant weight loss can also affect bone density. Adequate calcium, vitamin D, and protein during weight loss are important, and the growth-hormone-pathway compounds in this report have been associated with improved bone turnover markers in research contexts. If you have any history of low bone density, osteopenia, osteoporosis, or a prior fracture, raise it with your professional before beginning — it changes how this protocol should be approached. This is general educational information, not medical advice.
Section 9 — Adherence and consistency guidance
Making your educational framework sustainable
📌
Start narrow — build from there
Beginning with 1–2 compounds allows you and your professional to identify what is working, what needs adjusting, and what to add next. Starting with a full compound list at once makes it difficult to attribute changes — positive or negative — to any single compound.
🔁
What to do if you miss a day
For daily compounds: skip the missed dose and resume the following day. Do not double-dose. For 5-on/2-off compounds: the off days are built in — simply continue your schedule. For weekly compounds like Retatrutide: follow your prescriber's guidance on what to do if a scheduled dose is missed.
📅
Habit stacking for consistency
Attaching compound use to an existing daily habit — morning coffee, bedtime routine, pre-workout — significantly improves adherence. Set a phone reminder for each compound at its typical timing. Keep a consistent preparation area with supplies organized and accessible.
⚠️
When to pause and check in
Pause use and contact your professional if you experience: unexpected injection site reactions that worsen or spread, systemic symptoms (nausea, dizziness, rash, swelling), mood changes that feel significant or unusual, or any symptom you are uncertain about. Do not self-adjust dose or frequency without professional guidance.
📊
Evaluating results fairly
Do not evaluate the effectiveness of slow-onset compounds like GHK-Cu or Thymosin Alpha-1 within the first 30 days. Skin and immune changes are cumulative. Fast-onset compounds like Semax and Selank may provide quicker feedback. Use the 4-week tracker to observe changes systematically rather than relying on daily impressions.
Section 10 — Budget and supply planning
Mapping your $250–$500/mo budget to your compound list
Jennifer's budget of $250–$500/mo is realistic for a focused 2–3 compound approach. Running all seven compounds simultaneously would exceed most budgets in this range. The priority framework below is designed to help you and your professional decide where to start and what to add as results build.
Priority 1 — Highest impact anchorsStart here
CJC-1295 + Ipamorelin and GHK-Cu address Jennifer's two primary categories — hormone signaling and skin. These two compounds together typically fall within the $100–$200/mo range for research compound sourcing, leaving room within a $250–$500 budget for a third addition. Retatrutide (if prescribed) is pharmacy-priced separately.
Priority 2 — High-value additionsAdd when ready
Semax and Selank are relatively low-cost per vial and address Jennifer's high brain fog and mood scores directly. Adding one or both in month 2 once the primary compounds are established is a logical next step. Combined cost typically falls in the $50–$100/mo range.
Priority 3 — Supporting additionsPhase in later
MOTS-c and Thymosin Alpha-1 are supporting category compounds. MOTS-c is higher cost per vial — typically $80–$150/mo depending on sourcing and frequency. Thymosin Alpha-1 at 2x/week is typically $60–$100/mo for 2 vials. These are best introduced once the foundation is established and budget allows.
Important: Compound pricing varies significantly by source, concentration, and region. These are general educational cost estimates only. Always confirm pricing with your professional or pharmacy. Do not source compounds based solely on price — sterility, purity, and certification matter most.
Section 11 — Getting started
A practical orientation for moving forward
1
Know what you're using before you source it
Review every compound in this report before purchasing anything. Understand the dose, the reconstitution, the timing, and the syringe compatibility. If you are working with a knowledgeable professional, share this report with them. If you are self-directing, use this report as your educational foundation — not a shortcut.
2
Establish a bloodwork baseline
Ask your professional which baseline labs are appropriate before beginning — particularly relevant for hormone signaling, immune function, and the GLP-1 pathway given your age and profile.
3
Start with Priority 1 compounds
Begin with CJC-1295 + Ipamorelin and GHK-Cu — your two primary category anchors. Use the separate Peptide Schedule Reference Sheet delivered with this report as your daily guide.
4
Track weekly and observe
Use the 4-week tracker below to note energy, sleep, skin quality, and mood each week. Note any side effects or observations. Bring completed notes to your follow-up professional discussion.
Section 12 — 4-week outcome tracker
What to observe and note each week
How to use this tracker: At the end of each week, circle a number 1–5 for each area (1 = much worse · 3 = no change · 5 = noticeably better). Use the notes line to record observations, side effects, or questions. This tracker is designed to help you and your professional have a specific, data-informed follow-up conversation.
Week 1Orientation
Focus this week: establishing your routine, observing baseline, noting any early site reactions or changes.
Energy / Fatigue
12345
Notes / observations
Sleep Quality
12345
Notes / observations
Skin / Appearance
12345
Notes / observations
Mood / Clarity
12345
Notes / observations
Week 2Early response
Focus this week: noting any early neurological or energy shifts — Semax and Selank may show early signals.
Energy / Fatigue
12345
Notes / observations
Sleep Quality
12345
Notes / observations
Skin / Appearance
12345
Notes / observations
Mood / Clarity
12345
Notes / observations
Week 3Building
Focus this week: CJC-1295 + Ipamorelin sleep effects typically building — note sleep depth and morning energy.
Energy / Fatigue
12345
Notes / observations
Sleep Quality
12345
Notes / observations
Skin / Appearance
12345
Notes / observations
Mood / Clarity
12345
Notes / observations
Week 4Review
Focus this week: overall 30-day review — what improved, what needs adjusting, what to discuss at your follow-up.
Energy / Fatigue
12345
Notes / observations
Sleep Quality
12345
Notes / observations
Skin / Appearance
12345
Notes / observations
Mood / Clarity
12345
Notes / observations
PeptideReport.ai · 30-Day Full ReportPR-30-2026-10043 · May 21, 2026